On this episode of SO Files, Alston, Brad and Linda take a closer look at the recently published TAILORx Clinical Trial Published in NEJM by Sparano and colleagues. The study expands the existing clinical application of the Oncotype DX score. If that score sounds familiar its because it has been making its way into clinical practice over the past few years (see our last episode on the new AJCC guidelines!). We explain the origin of the score, how it has been incorporated into clinical practice thus far, and how this trial addresses a large gap in the existing literature.
Podden och tillhörande omslagsbild på den här sidan tillhör Brad Krasnick, Linda Jin, Alston James. Innehållet i podden är skapat av Brad Krasnick, Linda Jin, Alston James och inte av, eller tillsammans med, Poddtoppen.